(19)
(11) EP 1 171 593 A2

(12)

(88) Date of publication A3:
25.01.2001

(43) Date of publication:
16.01.2002 Bulletin 2002/03

(21) Application number: 00920910.7

(22) Date of filing: 20.04.2000
(51) International Patent Classification (IPC)7: C12N 15/12, C12N 5/10, C07K 14/705, C07K 16/28, C12Q 1/68, G01N 33/50, G01N 33/566
(86) International application number:
PCT/GB0001/546
(87) International publication number:
WO 0064/928 (02.11.2000 Gazette 2000/44)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 21.04.1999 GB 9909161

(71) Applicants:
  • SMITHKLINE BEECHAM PLC
    Brentford, Middlesex TW8 9EP (GB)
  • Max-Planck Institute of Neurobiology
    82152 Planegg-Martinsried (DE)

(72) Inventors:
  • BARDE, Yves-AlainMax-Planck Inst. of Neurobiology
    D-82152 Planegg-Martinsried (DE)
  • FRIEDEL, RolandMax-Planck Inst. of Neurobiology
    D-82152 Planegg-Martinsried (DE)
  • MICHALOVICH, DavidSmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)
  • REITH, Alastair David,SmithKline Beecham Pharm.
    Harlow,Essex CM19 5AW (GB)
  • SCHNUERCH, HaraldMax-Planck Inst. of Neurobiology
    D-82152 Planegg-Martinsried (DE)
  • STUBBUSCH, JuttaMax-Planck Inst. of Neurobiology
    D-82152 Planegg-Martinsried (DE)

(74) Representative: Connell, Anthony Christopher et al
GlaxoSmithKline, Two New Horizons Court
Brentford, Middlesex TW8 9EP
Brentford, Middlesex TW8 9EP (GB)

   


(54) TRANSMEMBRANE (7TM) RECEPTOR R35